Legal Framework · RUO Status · Compliance
Research-Grade GLP-1 Peptides —
Legal Framework & RUO Status
A factual overview of the federal regulatory framework governing research-grade GLP-1 peptide supply — for licensed practitioners, researchers, and qualified institutions.
This page provides general information about the legal framework for research peptide supply. It does not constitute legal advice. Licensed practitioners and researchers should consult qualified legal counsel regarding their specific compliance obligations. Nothing on this page should be construed as a statement of legality for any specific jurisdiction or use case.
Section 01
The RUO Framework
Understanding the federal designation that governs research compound supply — and how it differs from pharmaceutical regulation.
"Research Use Only" (RUO) is a federal designation for compounds supplied for laboratory and scientific research purposes. RUO compounds are not FDA-approved drugs — they are research materials supplied to qualified parties for scientific investigation.
- What RUO Means The compound itself is not approved for human therapeutic use. It is designated for research use by licensed professionals and qualified researchers. The designation governs the intended use and the customer relationship — not the molecule itself.
- Federal Legal Basis Supplying RUO compounds to licensed professionals and qualified researchers is legal under federal law. The FDA's authority over drugs centers on claims of therapeutic use, not on research supply to credentialed parties.
- The Critical Distinction FDA-approved pharmaceutical products and RUO research compounds occupy different regulatory categories. A compound may exist in both categories simultaneously — as a pharmaceutical product (e.g. Ozempic) and as a separate RUO research material — with entirely different regulatory frameworks governing each.
- Labeling Requirements RUO compounds must be clearly labeled "For Research Use Only — Not for use in diagnostic procedures" or equivalent language. No therapeutic claims. No human-use dosing language. These requirements are strictly observed at Sequence Labs.
Section 02
Who Can Legally Purchase Research Peptides
RUO compounds are not consumer products. Lawful supply requires credential verification and a documented B2B relationship.
MDs, DOs, PA-Cs, NPs, and other licensed healthcare providers with active state licensure.
Physicians and practitioners with active DEA registration for scheduled and regulated substances.
Universities, research labs, and institutional review board (IRB)-approved facilities conducting scientific research.
503A and 503B facilities with appropriate licensure, operating within their regulatory framework.
Research peptides are not sold to consumers without verified professional credentials. Sequence Labs is a B2B supplier only.
All accounts require credential documentation at setup. Orders are not processed prior to verification review.
Sequence Labs maintains a B2B-only supply model. Professional credentials are verified at account setup — not as a formality, but as the foundation of a compliant supply chain. This structure is what separates lawful RUO suppliers from general-market sellers.
Section 03
GLP-1 Compounds Specifically
Semaglutide, Tirzepatide, and Retatrutide — the research landscape, the pharmaceutical landscape, and why they are not the same market.
Pharmaceutical Products
FDA-Approved Drugs
Ozempic, Wegovy (semaglutide), Mounjaro, Zepbound (tirzepatide) — approved pharmaceutical products requiring valid prescriptions, dispensed by licensed pharmacies. Manufactured by Eli Lilly, Novo Nordisk. Subject to full pharmaceutical supply chain regulation.
RUO Research Materials
Research-Grade Compounds
Research-grade Semaglutide, Tirzepatide, and Retatrutide — supplied as RUO materials to licensed professionals and qualified researchers. Separate category from FDA-approved pharmaceuticals. Not supplied to the general public. Subject to RUO framework.
On the Peptide Sciences closure (March 2026): The voluntary closure of Peptide Sciences was company-specific — driven by a combination of operational, legal, and business factors particular to that organization. It was not a federal prohibition on GLP-1 research compound supply. The RUO framework governing research-grade GLP-1 supply remains unchanged.
On pharmaceutical manufacturer litigation: Eli Lilly and Novo Nordisk have pursued trademark and IP litigation against certain suppliers. Sequence Labs operates with a Montana LLC structure and a full compliance posture — no human-use claims, verified B2B customers only, and research-only language across all materials.
| Compound | Pharmaceutical Form | Manufacturer | RUO Research Form (Sequence Labs) |
|---|---|---|---|
| Semaglutide | Ozempic, Wegovy (injection); Rybelsus (oral) | Novo Nordisk | Lyophilized powder, RUO — licensed professionals only |
| Tirzepatide | Mounjaro, Zepbound (injection) | Eli Lilly | Lyophilized powder, RUO — licensed professionals only |
| Retatrutide | No approved pharmaceutical form (as of 2026) | Eli Lilly (Phase 3) | Lyophilized powder, RUO — licensed professionals only |
Section 04
The 503A / 503B Distinction
Compounding pharmacies and RUO research suppliers operate under distinct regulatory frameworks. Understanding the difference matters.
Compound patient-specific formulations pursuant to a valid prescription. Regulated primarily by state pharmacy boards. Must comply with USP standards. Patient-specific — not large-volume production. Governed by FDCA Section 503A.
May compound larger batches without patient-specific prescriptions. Subject to FDA inspection and cGMP standards. Greater regulatory oversight than 503A. Governed by FDCA Section 503B. May supply hospitals, clinics, and licensed practitioners.
Operate under the Research Use Only framework — distinct from compounding pharmacy regulation. Supply licensed professionals who may then work with 503A/503B pharmacies for patient-specific formulations. Sequence Labs operates within this framework.
Sequence Labs is not a compounding pharmacy and does not operate under 503A or 503B. The RUO framework is the applicable regulatory category. Licensed practitioners who purchase RUO compounds from Sequence Labs may engage separately with compounding pharmacies for patient-specific formulation under the appropriate frameworks — those are distinct, downstream relationships.
Section 05
How Sequence Labs Maintains Compliance
A compliance posture is not a single policy — it is a set of interlocking structural decisions that collectively define how a business operates within the legal framework.
-
Montana LLC Structure
Sequence Labs LLC is registered in Montana. Montana maintains favorable regulatory and tax structures for research compound businesses. The LLC structure provides appropriate liability separation and operational clarity. -
Practitioner Verification at Account Setup
B2B wholesale accounts require credential verification before order processing. Customers document their professional status — MD, DO, PA-C, NP, DEA registration, or institutional affiliation — at the time of account creation. -
PA-C and DEA-Registered Practitioner Catalog Review
The entire product catalog has been reviewed by a licensed PA-C and DEA-registered practitioner for catalog integrity and appropriate professional context. Research-use framing is enforced at the product level. -
Research-Only Language on All Materials
No therapeutic claims. No human-use language. No dosing guidance for human application. All product descriptions, packaging, and communications maintain strict research-use framing consistent with RUO designation. -
Batch-Specific COAs via Krause Analytical
Every product ships with access to a batch-specific Certificate of Analysis from Krause Analytical (Austin, TX). COAs are publicly verifiable via Finnrick Pulse. HPLC and mass spectrometry verification on every batch — not spot testing. -
Full Legal Documentation Available
Legal and compliance documentation is available at sequencelabs.health/legal.html. Terms of sale, RUO acknowledgment, and professional verification requirements are documented and retained.
Section 06
Frequently Asked Questions
Direct answers to the questions most commonly asked by licensed professionals and researchers about GLP-1 research compound legality.
Ready to work with a compliant supplier?
View the full research catalog or apply for a wholesale account — credentials verified at setup, batch COAs on every order.